Conclusion: The preliminary study suggests that IHW2 may have certain purging effect on leukemic cells and is safe for clinical application.

• 结论:初步研究显示亲溶酶体药物IHW2,用于临床移植患者是安全可行的，并且对白血病骨髓有一定的净化作用。